Haemonetics issues Q3 FY2025 earnings press release; no details available in input

HAEMONETICS CORP

2025-Q3 EPS reported $2.14 vs consensus $1.12 ▲ beat (+90.8%)

Filing reports results for Q3 and nine months ended December 28, 2024, via press release.
Press release is furnished as Exhibit 99.1 but was not included in the provided text.
No specific financial figures, guidance, or business updates are extractable from the given input.
The filing is a standard 8-K under Item 2.02; no other material events reported.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.